Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase I
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 30, 2013
Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase I
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 18, 2013
Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 18, 2013
Lead Product(s) : Laninamivir Octanoate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable